Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReproductive Health & FertilityHighmark Blueshield Neny IVF Coverage Prior Auth |…
    Ask Trek AI about this page
    CurrentHighmark Blueshield NenyPolicy CLM-140

    In Vitro Fertilization (IVF) Coverage Criteria

    Customize your policy alerts

    Sign up for Highmark Blueshield Neny Policy CLM-140 alerts

    Get alerted when Policy CLM-140 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical indications and prior authorization information for IVF coverage for Highmark BlueCross BlueShield Delaware members; intended for providers requesting authorization and documenting infertility diagnoses and prior treatments.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyIn Vitro Fertilization (IVF) Coverage Criteria
    Policy CodePolicy CLM-140
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionPrior authorization is required for IVF; providers must fax the completed questionnaire and supporting clinical documentation to the Medical Management and Policy Department.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    13

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    distinct clinical indication lines listed
    3criteria referencing prior failed cycles
    2fax numbers (DE)

    IVF Coverage Criteria

    Covered indications for IVF

    Covered when ONE of the following indications is met (each line describes a distinct qualifying indication):

    Female partner age ≥ 35 after attempting conception for ≥ 6 months.age ≥ 35 and ≥ 6 months attempted conception
    Evidence of diminished ovarian reserve defined by low AMH, persistent bilateral antral follicle count (AFC) < 5, or early follicular FSH ≥ 10.0, consistent over 2–3 determinations.AFC < 5; FSH ≥ 10.0; consistency on 2–3 tests
    Male factor infertility: ejaculated sperm unsuitable for IUI (poor count, motility, or morphology), <5% normal morphology by strict Kruger criteria, <5 million total motile sperm, or sperm obtainable only via urine, epididymal aspiration/testicular biopsy, or electroejaculation.<5% normal morphology OR <5 million total motile sperm
    Tubal disease: idiopathic or iatrogenic irreparable bilateral tubal occlusion, bilateral hydrosalpinx, prior bilateral salpingectomy, or severely abnormal tubes on laparoscopy.
    Severe pelvic adhesions diagnosed by laparoscopy.
    Prior laparotomy where laparoscopic evaluation is contraindicated, or severe pelvic adhesions diagnosed by laparoscopy.
    Polycystic Ovary Syndrome (PCOS) when ovulation induction with oral agents fails to produce follicular growth, or >3 ovulation induction cycles fail to result in conception, or when oral agents routinely produce >2 dominant follicles.>3 failed cycles or >2 dominant follicles with oral agents
    Recurrent pregnancy loss: 2–3 clinical pregnancy losses confirmed by ultrasound (age-dependent) with negative evaluation for underlying cause.2–3 clinical pregnancy losses (age-dependent)

    Chunk 8 specifies differing counts by maternal age.

    Balanced chromosome translocation in either partner when preimplantation genetic testing for structural rearrangements (PGT‑SR) would be performed.
    High risk for genetic disease in offspring: a dominant disorder in either partner or the same recessive disorder in both partners where preimplantation genetic testing for monogenic/single gene disorders (PGT‑M) would be used.
    Fertility preservation: embryo creation or oocyte cryopreservation prior to cancer treatment or other therapies toxic to ovaries/oocytes.
    Requirement for a gestational carrier due to prior hysterectomy, pregnancy medically contraindicated, or severe uterine anomaly.
    Unexplained infertility after failed ovulation induction/IUI: no successful conception after 3 properly managed ovulation induction cycles, with or without intrauterine insemination, managed by an OBGYN or reproductive endocrinologist.No conception after 3 properly managed cycles

    The source document does not include an explicit list of cosmetic or nonmedical exclusions. The IVF request form and accompanying materials ask for clinical history and supporting documentation for prior authorization but do not state any specific exclusions for cosmetic or nonmedical indications.

    The document contains no explicit statements labeling services or scenarios as "not medically necessary." The form focuses on collecting clinical history, infertility work-up, tests, proposed treatment, and supporting documentation for prior authorization without providing named "not medically necessary" language.

    Codes, Thresholds, and Numeric Criteria

    Prior authorization affected codesmixed
    affected codesPlaceholder - document references prior authorization for IVF but does not list specific CPT/HCPCS/ICD codes.
    Documented numeric thresholds and counts (key values)
    Antral follicle count (AFC)Persistent bilateral AFC < 5.0 (consistent across determinations)
    Early follicular FSHEarly follicular FSH ≥ 10.0 (consistent over 2–3 determinations)
    Anti‑Müllerian hormone (AMH)Low AMH documented (used as diagnostic criterion for diminished ovarian reserve)
    Sperm morphology< 5% normal forms by strict Kruger criteria
    Total motile sperm< 5 million total motile sperm
    Failed ovulation induction cycles> 3 ovulation induction cycles without conception (e.g., for PCOS or unexplained infertility after properly managed cycles)

    Prior Authorization & Submission Requirements

    Prior Authorization

    Prior authorization required for IVF

    Prior authorization is required for In Vitro Fertilization. Providers must fax the completed IVF questionnaire and all supporting clinical documentation to the Medical Management and Policy Department for review prior to services.

    Step Therapy

    Required prior failed cycles for some indications

    Certain indications require documented prior failed ovulation induction cycles before IVF is covered: for PCOS, more than 3 ovulation induction cycles that fail to result in conception (or settings where oral agents routinely produce >2 dominant follicles); for unexplained infertility, no successful conception after 3 properly managed ovulation induction cycles, with or without IUI.

    • PCOS: >3 failed ovulation induction cycles (or >2 dominant follicles with oral agents).
    • Unexplained infertility: no conception after 3 properly managed ovulation induction cycles, with or without IUI.

    Clinical Background

    Infertility is multifactorial and may reflect female factors such as advanced maternal age or diminished ovarian reserve, male factors affecting sperm count, motility, or morphology, or anatomic conditions such as tubal disease or severe pelvic adhesions. Prior pelvic surgery (for example prior laparotomy or salpingectomy) can affect fertility by producing adhesions or irreparable tubal damage. Anovulation from conditions like polycystic ovary syndrome and assisted-reproduction‑relevant genetic or uterine conditions (for example chromosomal rearrangements or uterine anomalies requiring a gestational carrier) are also recognized contributors. The form requests a brief patient history and infertility work-up and tests so the submitted documentation can demonstrate which of these clinical causes applies for prior authorization review.

    Key Definitions

    Diminished Ovarian Reserve — diagnostic criteria
    Primary diagnostic testsAnti‑Müllerian hormone (AMH) — low AMH consistent with diminished reserve
    Antral follicle count (AFC)Persistent bilateral AFC < 5.0 (must be consistent across determinations)
    Early follicular FSHEarly follicular FSH ≥ 10.0 (consistent across 2–3 determinations)
    Determination frequencyFindings (AFC/FSH) should be consistent over 2–3 determinations
    Male factor infertility (severe) — diagnostic criteria
    IUI suitabilityEjaculated sperm unsuitable for IUI due to poor count, motility, or morphology
    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyIn Vitro Fertilization (IVF) Coverage Criteria
    Policy CodePolicy CLM-140
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionPrior authorization is required for IVF; providers must fax the completed questionnaire and supporting clinical documentation to the Medical Management and Policy Department.
    SourceLink
    On This Page
    IVF Coverage CriteriaCodes, Thresholds, and Numeric CriteriaPrior Authorization & Submission RequirementsClinical BackgroundKey Definitions
    Documentation Required

    Required prior authorization submission materials

    Providers must submit a completed IVF request questionnaire including brief patient history, infertility work‑up and treatments, medications, surgeries, tests and results, the specified cause of infertility, proposed treatment, and the provider signature; supporting clinical documentation should be faxed to the Medical Management and Policy Department.

    • Brief patient history
    • Infertility work‑up and treatments, medications, surgeries
    • Tests and results
    • Cause of infertility and proposed treatment
    • Provider signature and contact information
    Denial Risk

    Submit completed questionnaire and documentation via specified fax

    Failure to fax the completed IVF questionnaire and supporting clinical documentation to the Medical Management and Policy Department via the listed fax numbers may prevent prior authorization and result in denial.

    • Fax numbers for submission: 800.670.4862 (Delaware) or 888.236.6321
    Morphology threshold
    < 5% normal morphology by strict Kruger criteria
    Total motile sperm threshold< 5 million total motile sperm
    Sperm obtainable only by specialized methodsSperm only obtainable from urine (retrograde ejaculation), epididymal aspiration/testicular biopsy, or electroejaculation